You are here: Home » Products » Veterinary medicine » Injection » Veterinary Drugs Oxytetracycline 20% Injection 100ml

Product Detail

loading

Share to:

Veterinary Drugs Oxytetracycline 20% Injection 100ml

  • 100ml
  • Ouke
Availability:
Quantity:

CPMPOSITION:

Each ml contains:

Oxytetracycline base.................200mg


INDICATIONS:

OXYTET-LA 200 is specifically formulated to provide a prolonged action resulting in sustained antibacterial activity. After administration by the intramuscular route. Maximum blood levels are achieved after 4 to 8 hours making OXYTET-LA 200 suitable for the treatment of acute infections. OXYTET-LA 200 is indicated for the treatment of arthritis, gastrointestinal and respiratory infections caused by oxytetracycline sensitive micro-organisms, like Bordetella, Campylobacter, Chlamydia, E.coli, Haemophilus, Mycoplasma, Pasteurella, Rickettsia, Salmonella, Staphylococcus spp.


DOSAGE AND ADMINISTRATION:

For intramuscular administration.

A single of dose of 1ml/10kg body weight is sufficient to treat minor to moderate infections caused by susceptible bacteria and other microorganisms. Do not administer more than 15ml in camels, cattle and more than 5ml in calves, goats and sheep per same injection site.


CONTRA-INDICATIONS:

Do not use the product in ewes producing milk for human consumption.

Do not use in animals suffering from renal or hepatic impairment.

Hypersensitivity to tetracycline.


STORAGE:

Store below 25ºC.

Protect from light.


Previous: 
Next: 

CONTACT US

Add : 8f, Building 11, Liye Park, Qilin Hi-Tech Industrial Development Zone, Jiangning, Nanjing, Jiangsu, China.
Phone : 86-18936019852
E-mail : eric@oudoli.com

 SUBSCRIBE NEWSLETTER

ABOUT US

It is mainly deals in export medicine, veterinary drug, surgical and competitive medical products.

QUICK LINKS

PRODUCTS

CONTACT INFO

    Add : 8f, Building 11, Liye Park, Qilin Hi-Tech Industrial Development Zone, Jiangning, Nanjing, Jiangsu, China
    Phone : 025-85091392
    E-mail : eric@oudoli.com
Copyright  2021  Jiangsu oudoli Pharmaceutical Co., Ltd. Sitemap